For the latest ecancer COVID-19 resources, click on this link

Videos [754]
News [1754]
Articles [88]
Editorials [6]
Conferences [51]
elearning [7]
COVID-19 and cancer: Useful resources
COVID-19 and cancer: Useful resources
ESMO 2020: Two-pronged attack using new targeted drug could treat ‘addicted’ prostate cancers
ESMO 2020: Two-pronged attack using new targeted drug could treat ‘addicted’ prostate cancers
Scientists identify dozens of genes allowing cancer cells to evade the immune system
Scientists identify dozens of genes allowing cancer cells to evade the immune system
The future of care in metastatic urothelial carcinoma and the role of the FGFR pathway
The future of care in metastatic urothelial carcinoma and the role of the FGFR pathway
Why some cancers may respond poorly to key drugs discovered
Why some cancers may respond poorly to key drugs discovered
ESMO 2020: Immunotherapy combination improves outcomes in advanced kidney cancer
ESMO 2020: Immunotherapy combination improves outcomes in advanced kidney cancer
ESMO 2020: PARP inhibitor olaparib for the targeted treatment of metastatic prostate cancer
ESMO 2020: PARP inhibitor olaparib for the targeted treatment of metastatic prostate cancer
ESMO 2020: New first-line treatment option for metastatic kidney cancer, according to results of phase 3 study
ESMO 2020: New first-line treatment option for metastatic kidney cancer, according to results of pha...
Immunotherapy improves survival in advanced bladder cancer patients
Immunotherapy improves survival in advanced bladder cancer patients
Algorithms uncover cancers' hidden genetic losses and gains
Algorithms uncover cancers' hidden genetic losses and gains

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation